Whitehawk Therapeutics Inc (WHWK)

Currency in USD
2.6500
+0.1600(+6.43%)
Closed·
2.65000.0000(0.00%)
·
WHWK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.44002.7100
52 wk Range
1.39003.8120
Key Statistics
Prev. Close
2.49
Open
2.47
Day's Range
2.44-2.71
52 wk Range
1.39-3.812
Volume
320.6K
Average Volume (3m)
1.74M
1-Year Change
-7.34%
Book Value / Share
3.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WHWK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.0000
Downside
-24.53%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Whitehawk Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Whitehawk Therapeutics Company Profile

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Employees
22

Compare WHWK to Peers and Sector

Metrics to compare
WHWK
Peers
Sector
Relationship
P/E Ratio
−8.0x−3.0x−0.6x
PEG Ratio
−0.090.100.00
Price/Book
0.8x2.9x2.6x
Price / LTM Sales
8.7x43.3x3.2x
Upside (Analyst Target)
−19.7%219.5%41.8%
Fair Value Upside
Unlock−4.7%5.1%Unlock

Analyst Ratings

0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2.0000
(-24.53% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jones Trading
Buy7.00+164.15%-New Coverage22/12/2025
Jefferies
Hold2.00-24.53%-Maintain20/11/2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.26 / -0.48
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

2.180
CABA
-8.79%
11.9600
TENX
-4.01%
3.040
AMPG
+0.33%
116.64
KALU
+0.50%
77.70
PTCT
-1.52%

FAQ

What Is the Whitehawk Therapeutics (WHWK) Share Price Today?

The live Whitehawk Therapeutics share price today is 2.6500

What Stock Exchange Does Whitehawk Therapeutics (WHWK) Trade On?

Whitehawk Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Whitehawk Therapeutics?

The stock symbol (also called a 'ticker') for Whitehawk Therapeutics is "WHWK."

What Is the Current Whitehawk Therapeutics Market Cap?

As of today, Whitehawk Therapeutics market capitalisation is 124.89M.

What Is Whitehawk Therapeutics's (WHWK) Earnings Per Share (TTM)?

The Whitehawk Therapeutics EPS is currently -0.31 (Trailing Twelve Months).

When Is the Next Whitehawk Therapeutics Earnings Date?

Whitehawk Therapeutics's next earnings report will be released on 12 Mar 2026.

Is WHWK a Buy or Sell From a Technical Analyst Perspective?

Based on today's Whitehawk Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Whitehawk Therapeutics Stock Split?

Whitehawk Therapeutics has split 1 times. (See the WHWK stock split history page for full effective split date and price information.)

How Many Employees Does Whitehawk Therapeutics Have?

Whitehawk Therapeutics has 22 employees.

What is the current trading status of Whitehawk Therapeutics (WHWK)?

As of 24 Dec 2025, Whitehawk Therapeutics (WHWK) is trading at a price of 2.6500, with a previous close of 2.4900. The stock has fluctuated within a day range of 2.4400 to 2.7100, while its 52-week range spans from 1.3900 to 3.8120.

What Is Whitehawk Therapeutics (WHWK) Price Target According to Analysts?

The average 12-month price target for Whitehawk Therapeutics is USD2, with a high estimate of USD2 and a low estimate of USD2. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -24.53% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.